SteelPeak Wealth’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Sell
5,677
-13,860
-71% -$902K 0.02% 398
2026
Q1
$928K Sell
19,537
-1,331
-6% -$59.7K 0.03% 299
2025
Q4
$662K Buy
20,868
+2,570
+14% +$80.2K 0.02% 323
2025
Q3
$515K Buy
18,298
+11,616
+174% +$352K 0.02% 384
2025
Q2
$246K Sell
6,682
-646
-9% -$22.3K 0.01% 449
2025
Q1
$288K Buy
7,328
+86
+1% +$3.87K 0.01% 422
2024
Q4
$337K Sell
7,242
-1,970
-21% -$89K 0.01% 394
2024
Q3
$416K Buy
+9,212
New +$438K 0.02% 342
2024
Q1
Sell
-7,249
Closed -$267K 550
2023
Q4
$267K Sell
7,249
-9,759
-57% -$226K 0.02% 349
2023
Q3
$345K Buy
+17,008
New +$374K 0.02% 309
2023
Q2
Sell
-18,076
Closed -$273K 502
2023
Q1
$273K Buy
+18,076
New +$399K 0.02% 318
2022
Q1
Sell
-2,973
Closed -$230K 487
2021
Q4
$230K Sell
2,973
-213
-7% -$21.9K 0.01% 368
2021
Q3
$341K Sell
3,186
-862
-21% -$98.7K 0.02% 309
2021
Q2
$539K Buy
4,048
+1,671
+70% +$194K 0.04% 259
2021
Q1
$294K Buy
+2,377
New +$361K 0.02% 304

Other funds holding TWST

SteelPeak Wealth's TWST Position: Q2 2026 in Review

SteelPeak Wealth reduced its Twist Bioscience (TWST) stake by 71% in Q2 2026, selling an estimated $902K and leaving 5,677 shares worth $584K. The position accounts for 0.02% of the portfolio, ranked #398.

SteelPeak Wealth first reported a position in TWST in Q1 2021 and has held it in 15 quarters since. The position peaked at $928K in Q1 2026. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • SteelPeak Wealth held 5,677 shares of Twist Bioscience worth $584K as of Q2 2026.
  • SteelPeak Wealth sold 13,860 Twist Bioscience shares in Q2 2026, an estimated $902K.
  • Twist Bioscience made up 0.02% of SteelPeak Wealth's portfolio in Q2 2026, its #398 holding.
  • SteelPeak Wealth first reported a position in Twist Bioscience in Q1 2021 and has held it in 15 quarters since.
  • SteelPeak Wealth's Twist Bioscience position peaked at $928K in Q1 2026.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.